Multidimensional landscape of non‐alcoholic fatty liver disease‐related disease spectrum uncovered by big omics data: Profiling evidence and new perspectives

Abstract Characterized by hepatic lipid accumulation, non‐alcoholic fatty liver disease (NAFLD) is a multifactorial metabolic disorder that could promote the progression of non‐alcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma (HCC). Benefiting from recent advances in omics t...

Full description

Bibliographic Details
Main Authors: Zhengyi Zhu, Yuyan Chen, Xueqian Qin, Shujun Liu, Jinglin Wang, Haozhen Ren
Format: Article
Language:English
Published: Wiley-VCH 2023-05-01
Series:Smart Medicine
Subjects:
Online Access:https://doi.org/10.1002/SMMD.20220029
_version_ 1797796706086027264
author Zhengyi Zhu
Yuyan Chen
Xueqian Qin
Shujun Liu
Jinglin Wang
Haozhen Ren
author_facet Zhengyi Zhu
Yuyan Chen
Xueqian Qin
Shujun Liu
Jinglin Wang
Haozhen Ren
author_sort Zhengyi Zhu
collection DOAJ
description Abstract Characterized by hepatic lipid accumulation, non‐alcoholic fatty liver disease (NAFLD) is a multifactorial metabolic disorder that could promote the progression of non‐alcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma (HCC). Benefiting from recent advances in omics technologies, such as high‐throughput sequencing, voluminous profiling data in HCC‐integrated molecular science into clinical medicine helped clinicians with rational guidance for treatments. In this review, we conclude the majority of publicly available omics data on the NAFLD‐related disease spectrum and bring up new insights to inspire next‐generation therapeutics against this increasingly prevalent disease spectrum in the post‐genomic era.
first_indexed 2024-03-13T03:37:06Z
format Article
id doaj.art-124302d2eaab4eef8920c3f23d81f892
institution Directory Open Access Journal
issn 2751-1871
language English
last_indexed 2024-03-13T03:37:06Z
publishDate 2023-05-01
publisher Wiley-VCH
record_format Article
series Smart Medicine
spelling doaj.art-124302d2eaab4eef8920c3f23d81f8922023-06-23T15:10:28ZengWiley-VCHSmart Medicine2751-18712023-05-0122n/an/a10.1002/SMMD.20220029Multidimensional landscape of non‐alcoholic fatty liver disease‐related disease spectrum uncovered by big omics data: Profiling evidence and new perspectivesZhengyi Zhu0Yuyan Chen1Xueqian Qin2Shujun Liu3Jinglin Wang4Haozhen Ren5Department of Hepatobiliary Surgery Affiliated Drum Tower Hospital Medical School Nanjing University Nanjing ChinaDepartment of Hepatobiliary Surgery Affiliated Drum Tower Hospital Medical School Nanjing University Nanjing ChinaDepartment of Hepatobiliary Surgery Affiliated Drum Tower Hospital Medical School Nanjing University Nanjing ChinaDepartment of Hepatobiliary Surgery Affiliated Drum Tower Hospital Medical School Nanjing University Nanjing ChinaDepartment of Hepatobiliary Surgery Affiliated Drum Tower Hospital Medical School Nanjing University Nanjing ChinaDepartment of Hepatobiliary Surgery Affiliated Drum Tower Hospital Medical School Nanjing University Nanjing ChinaAbstract Characterized by hepatic lipid accumulation, non‐alcoholic fatty liver disease (NAFLD) is a multifactorial metabolic disorder that could promote the progression of non‐alcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma (HCC). Benefiting from recent advances in omics technologies, such as high‐throughput sequencing, voluminous profiling data in HCC‐integrated molecular science into clinical medicine helped clinicians with rational guidance for treatments. In this review, we conclude the majority of publicly available omics data on the NAFLD‐related disease spectrum and bring up new insights to inspire next‐generation therapeutics against this increasingly prevalent disease spectrum in the post‐genomic era.https://doi.org/10.1002/SMMD.20220029HCCNAFLDNASHomics datasequencing
spellingShingle Zhengyi Zhu
Yuyan Chen
Xueqian Qin
Shujun Liu
Jinglin Wang
Haozhen Ren
Multidimensional landscape of non‐alcoholic fatty liver disease‐related disease spectrum uncovered by big omics data: Profiling evidence and new perspectives
Smart Medicine
HCC
NAFLD
NASH
omics data
sequencing
title Multidimensional landscape of non‐alcoholic fatty liver disease‐related disease spectrum uncovered by big omics data: Profiling evidence and new perspectives
title_full Multidimensional landscape of non‐alcoholic fatty liver disease‐related disease spectrum uncovered by big omics data: Profiling evidence and new perspectives
title_fullStr Multidimensional landscape of non‐alcoholic fatty liver disease‐related disease spectrum uncovered by big omics data: Profiling evidence and new perspectives
title_full_unstemmed Multidimensional landscape of non‐alcoholic fatty liver disease‐related disease spectrum uncovered by big omics data: Profiling evidence and new perspectives
title_short Multidimensional landscape of non‐alcoholic fatty liver disease‐related disease spectrum uncovered by big omics data: Profiling evidence and new perspectives
title_sort multidimensional landscape of non alcoholic fatty liver disease related disease spectrum uncovered by big omics data profiling evidence and new perspectives
topic HCC
NAFLD
NASH
omics data
sequencing
url https://doi.org/10.1002/SMMD.20220029
work_keys_str_mv AT zhengyizhu multidimensionallandscapeofnonalcoholicfattyliverdiseaserelateddiseasespectrumuncoveredbybigomicsdataprofilingevidenceandnewperspectives
AT yuyanchen multidimensionallandscapeofnonalcoholicfattyliverdiseaserelateddiseasespectrumuncoveredbybigomicsdataprofilingevidenceandnewperspectives
AT xueqianqin multidimensionallandscapeofnonalcoholicfattyliverdiseaserelateddiseasespectrumuncoveredbybigomicsdataprofilingevidenceandnewperspectives
AT shujunliu multidimensionallandscapeofnonalcoholicfattyliverdiseaserelateddiseasespectrumuncoveredbybigomicsdataprofilingevidenceandnewperspectives
AT jinglinwang multidimensionallandscapeofnonalcoholicfattyliverdiseaserelateddiseasespectrumuncoveredbybigomicsdataprofilingevidenceandnewperspectives
AT haozhenren multidimensionallandscapeofnonalcoholicfattyliverdiseaserelateddiseasespectrumuncoveredbybigomicsdataprofilingevidenceandnewperspectives